Yale Catriona

CIK 00017793081 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001779308

Recent Transactions

50 trades

Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−33,421→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−3,421→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−52,785→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−47,573→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−5,032→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−131,205→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−27,227→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−70,279→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−84,051→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−74,053→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−2,328→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-04−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-04−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-04$28.35/sh+3,527→ 70,061 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-04$21.10/sh+4,739→ 74,800 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-11$43.02/sh−659→ 90,829 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-07-16$53.47/sh−1,342→ 91,488 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-16−10,000→ 131,205 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-07-16$52.87/sh−8,658→ 92,830 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-07-16$19.87/sh+10,000→ 101,488 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-30$23.87/sh+890→ 91,488 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-18$54.84/sh−1,633→ 90,598 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-16$55.52/sh−895→ 92,231 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-16$54.80/sh−2,895→ 93,126 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-16−10,000→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-06-16$21.10/sh+10,000→ 102,231 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-16$53.78/sh−6,210→ 96,021 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-10$54.00/sh−2,803→ 92,231 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-05-15$21.10/sh+10,000→ 105,034 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-05-15−10,000→ 10,000 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-05-15$39.91/sh−4,384→ 95,034 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-05-15$39.46/sh−2,779→ 99,418 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-05-15$38.20/sh−2,837→ 102,197 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-04-15−9,073→ 20,000 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-04-15$21.10/sh+9,073→ 104,107 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-04-15$37.80/sh−7,873→ 96,234 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-04-15$38.62/sh−1,200→ 95,034 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-03-17$44.70/sh−8,201→ 96,833 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-03-17$45.05/sh−1,799→ 95,034 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-03-17$21.10/sh+10,000→ 105,034 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-03-17−10,000→ 0 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-03-12$44.88/sh−614→ 95,034 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-02-18$50.63/sh−900→ 95,648 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-02-18$21.10/sh+10,000→ 105,648 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-02-18−10,000→ 10,000 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-02-18$49.79/sh−9,100→ 96,548 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-27−16,849→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-27−641→ 0 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-01-27$55.95/sh−9,250→ 122,988 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-27−20,000→ 0 total

Companies

Akero Therapeutics, Inc.
Chief Development Officer

Recent Filings

Address

601 GATEWAY BOULEVARD SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov